LipoScience says data shows lipoprotein particle control helps disease

theflyonthewall.com

LipoScience announced the online publication of data in the Journal of Clinical Lipidology demonstrating the economic benefits of managing to a low-density lipoprotein particle number measured by NMR as part of a cardiovascular disease risk-reduction strategy. The study is the first of several anticipated publications to establish the economic value proposition for LDL-P. This study models the economic benefits of managing to both LDL-P and low-density lipoprotein cholesterol targets, in comparison to managing LDL-C alone, to help reduce cardiovascular events and associated costs.

Rates

View Comments (0)